UPSC Medical Science 2022 — Paper I

The directive 'discuss' demands a comprehensive, analytical treatment across all five sub-parts. Allocate approximately 30% of time/words to part (a) given its 15 marks, 20% each to parts (b), (c), and (e) at 10 marks each, and 10% to part (d) at 5 marks. Structure with brief introductions for anatomical parts, detailed physiological mechanisms with Indian epidemiological context where relevant, and conclude with clinical significance for each sub-part.

• Part (a): Stomach anatomy—lesser/greater omentum relations, coeliac trunk branches (left gastric, splenic, common hepatic), and lymphatic drainage via gastric, hepatic, and splenic nodes to coeliac nodes
• Part (b): GH regulation—hypothalamic GHRH and somatostatin control, IGF-1 negative feedback, pulsatile secretion; functions include linear growth via epiphyseal plates, protein anabolism, lipolysis, and diabetogenic effects
• Part (c): Physiological jaundice—unconjugated hyperbilirubinemia 2-3 mg/dL peaking day 3-5 due to immature UDP-glucuronyl transferase, predisposed by prematurity, breastfeeding, G6PD deficiency (common in India), hemolysis; effects include kernicterus risk
• Part (d): Renal anomalies—horseshoe kidney (fusion), pelvic kidney (ectopia), polycystic kidney disease, double ureter, ureteropelvic junction obstruction, and vesicoureteral reflux
• Part (e): Placental hormones—hCG (corpus luteum rescue), hPL (maternal metabolic adaptation), progesterone and estrogen (maintain pregnancy), relaxin (pelvic relaxation), and their integrated endocrine functions

The directive 'describe' demands comprehensive, structured coverage of anatomical details for (a), while (b) requires 'discuss' for physiological mechanisms, and (c) needs 'explain' for molecular processes. Allocate approximately 30% time/words to (a) given its multi-heading structure, 30% to (b) for baroreceptor and renal mechanisms, 20% to (c)(i) for initiation steps and inhibitors, and 20% to (c)(ii) for RIA principle and clinical applications. Structure each part with clear sub-headings matching the question, use diagrams liberally, and conclude with applied relevance for each section.

• (a) Uterus: pear-shaped, 7.5×5×2.5 cm, three parts (fundus, body, cervix), peritoneal relations (vesicouterine and rectouterine pouches), cardinal/uterosacral/pubocervical ligaments, uterine and ovarian arteries, lymphatics to internal iliac and para-aortic nodes, applied: prolapse, hysterectomy planes
• (b) Short-term regulation: baroreceptor reflex (carotid sinus, aortic arch), chemoreceptors, CNS ischemic response; Long-term: renal-body fluid mechanism, RAAS, ADH, natriuretic peptides, capillary fluid shift
• (c)(i) Eukaryotic initiation: 43S pre-initiation complex, 5' cap recognition (eIF4F), scanning, AUG codon, 80S assembly; inhibitors: tetracycline (30S), chloramphenicol (50S peptidyl transferase), erythromycin (translocation), puromycin (premature termination)
• (c)(ii) RIA principle: competitive binding, radiolabeled antigen vs unlabeled antigen for limited antibody sites, standard curve, sensitivity (pg/mL); applications: T3/T4, insulin, cortisol, HCG, drug levels, tumor markers (PSA, AFP)
• Integration: hormonal cross-talk (estrogen-progesterone on uterus, RAAS on blood pressure), clinical diagnostics (RIA in thyroid disorders, pregnancy), therapeutic implications (antibiotics targeting protein synthesis)

The directive 'discuss' demands a comprehensive, analytical treatment with balanced coverage across all four sub-parts. Allocate approximately 20% (10 marks) to (a)(i) basal ganglia and Parkinson's, 20% (10 marks) to (a)(ii) excitation-contraction coupling, 30% (15 marks) to (b) vitamin A biochemistry and deficiency, and 30% (15 marks) to (c)(i) facial nerve and (c)(ii) rotator cuff combined. Structure with brief introductions for each sub-part, detailed mechanistic explanations in the body, and applied/clinical conclusions. For (a)(ii) and facial nerve, prioritize labeled diagrams.

• Basal ganglia: motor control loops (direct/indirect pathways), role in movement initiation and inhibition; Parkinson's: dopaminergic neuron loss in substantia nigra pars compacta, Lewy bodies, TRAP symptoms
• Excitation-contraction coupling: T-tubule depolarization, DHP receptors, RyR1 calcium release, calcium-troponin C binding, cross-bridge cycling, SERCA-mediated relaxation
• Vitamin A derivatives: retinal (vision/rhodopsin), retinoic acid (gene transcription/RAR/RXR), retinol (transport/storage); deficiency causes: dietary (India's ICDS program relevance), malabsorption, liver disease; manifestations: night blindness, Bitot's spots, xerophthalmia, keratomalacia; management: oral retinol, IM in malabsorption, prevention through VAS program
• Facial nerve: functional components (SVE, SVA, GVE, GSA), course through internal acoustic meatus, facial canal, stylomastoid foramen; branches: greater petrosal, chorda tympani, posterior auricular, temporal/zygomatic/buccal/mandibular/cervical; applied: Bell's palsy, House-Brackmann grading, corneal protection
• Rotator cuff: SITS muscles (supraspinatus, infraspinatus, teres minor, subscapularis) attachments to greater/lesser tubercles; applied: impingement syndrome, painful arc, tears in repetitive overhead workers

The directive 'explain' demands clear mechanistic and causal reasoning across all sub-parts. Allocate approximately 40% time to (a)(i) iron absorption (15 marks), 15% to (a)(ii) TFT (5 marks), 30% to (b) stretch reflex including diagram (15 marks), 10% to (c)(i) mammary lymphatics (5 marks), and 25% to (c)(ii) IV septum development (10 marks). Structure as: brief introduction → systematic part-wise coverage with diagrams where required → integrated clinical conclusion.

• (a)(i) Mechanism: DMT1-mediated uptake at apical membrane, ferroportin/FPN1 export at basolateral membrane, hepcidin regulation, and distinction between heme vs non-heme iron absorption
• (a)(i) Regulatory factors: Hepcidin-ferroportin axis, body iron stores, erythropoietic demand, hypoxia, and dietary enhancers/inhibitors (vitamin C, phytates, calcium)
• (a)(ii) TFT diagnostic role: TSH as screening test, FT4/FT3 patterns in primary vs secondary vs tertiary thyroid disorders, and interpretation in pregnancy/subclinical states
• (b)(i) Stretch reflex diagram: Muscle spindle structure (intrafusal fibers, annulospiral/flower-spray endings), Ia afferent, alpha motor neuron, and efferent to extrafusal fibers with reciprocal inhibition
• (b)(ii) Functions: Muscle tone maintenance, postural reflex, and clinical applications: deep tendon reflexes (knee jerk, ankle jerk), clonus testing, and upper vs lower motor neuron lesion differentiation
• (c)(i) Mammary lymphatics: Axillary nodes (pectoral, subscapular, lateral, central, apical groups), parasternal/internal mammary nodes, and clinical significance in breast cancer staging and sentinel node biopsy
• (c)(ii) IV septum development: Muscular septum from trabeculated muscle, membranous septum from endocardial cushions and conus septum, and related anomaly: VSD (membranous vs muscular types, with mention of Tetralogy of Fallot if aortic override discussed)

The directive 'describe' demands comprehensive, structured exposition across all six sub-parts. Allocate approximately 20% (10 marks) each to parts (a), (c), (d), and (e), with 10% (5 marks) each to (b)(i) and (b)(ii). Begin with molecular mechanisms of breast carcinogenesis, proceed through immunology, infectious diseases, pharmacology, pathology, and forensic medicine—ensuring each section has a clear sub-heading. For (b)(i), dedicate time to drawing a neat, labelled IgA diagram. Conclude each part with clinical relevance or public health significance where applicable.

• Part (a): Molecular mechanisms—BRCA1/BRCA2 mutations, HER2/neu amplification, ER/PR signaling, TP53 mutations; histopathology of invasive carcinoma NST—tubule formation, nuclear pleomorphism, mitotic count (Nottingham grading), desmoplastic stroma, lymphovascular invasion
• Part (b)(i): Diagram of IgA showing two heavy chains (α1/α2), two light chains, J chain, secretory component; role in mucosal immunity—selective IgA deficiency, celiac disease, IgA nephropathy (Berger disease)
• Part (b)(ii): Definition of opportunistic infections (pathogens causing disease in immunocompromised hosts); AIDS-related infections—bacterial (Mycobacterium avium complex, TB), parasitic (Toxoplasma, Cryptosporidium, Pneumocystis jirovecii), viral (CMV, HSV, JC virus), fungal (Cryptococcus, Candida, Histoplasma)
• Part (c): ARB mechanism—selective AT1 receptor blockade (losartan, valsartan, telmisartan); differences from ACE inhibitors—no bradykinin accumulation (no cough/angioedema), no effect on B2 receptors; hypertensive emergency—IV labetalol/esmolol/nitroprusside, oral/nicardipine, avoid sublingual nifedipine
• Part (d): Definition—granulomatous inflammation as specialized chronic inflammation with epithelioid histiocytes; types—infectious (tuberculosis, leprosy, syphilis, fungal), foreign body (silica, suture), sarcoidosis, Crohn's disease, Wegener's granulomatosis, pathogenesis (Th1 response, IL-12, IFN-γ, TNF-α)
• Part (e): Firearm definition—weapon using explosive propellant; entry wound features—range (contact, close <1m, distant), abrasion collar/grease collar, soot/tattooing, stellate laceration (contact), direction—inverted/converted wound shape, bevelling (inward in skull entry, outward in exit)

The directive 'describe' demands systematic exposition of pathogenetic mechanisms, histopathological features, drug profiles, and parasitic disease characteristics. Allocate approximately 25% time to (a)(i) RHD pathogenesis and histopathology, 25% to (a)(ii) cirrhosis etiology and histopathology, 20% to (b) pharmacology of both drugs covering indications, interactions and adverse effects, 15% to (c)(i) Giardia morphology, clinical features and lab diagnosis, and 15% to (c)(ii) dengue serotypes, pathogenesis and DHF diagnosis. Structure each sub-part with definition/introduction, detailed body covering all command terms, and brief concluding significance.

• RHD: Molecular mimicry (Streptococcus pyogenes M protein cross-reaction with cardiac myosin), Aschoff body histology (Anitschkow cells, granulomatous inflammation), valvular involvement pattern (mitral > aortic)
• Cirrhosis: Two important causes (alcoholic liver disease and chronic viral hepatitis B/C in Indian context), histopathology showing fibrous septa, regenerative nodules, loss of lobular architecture, Mallory bodies if alcoholic
• Celecoxib: COX-2 selective NSAID indications (rheumatoid arthritis, osteoarthritis, familial adenomatous polyposis), interactions (warfarin, ACE inhibitors, diuretics), cardiovascular and GI side effects
• Chloroquine: Antimalarial (P. vivax/P. ovale radical cure, P. falciparum clinical cure), amebicidal, immunomodulatory uses; interactions (digoxin, antiepileptics), retinopathy, cardiomyopathy side effects
• Giardia lamblia: Flagellated protozoan, trophozoite and cyst morphology, malabsorption diarrhea, steatorrhea, trophozoite in duodenal aspirate/cyst in stool, string test, ELISA for antigen detection
• Dengue: Four serotypes (DEN-1 to DEN-4), antibody-dependent enhancement in DHF/DSS pathogenesis, NS1 antigen detection, IgM/IgG serology, RT-PCR, tourniquet test, thrombocytopenia and hematocrit rise as lab markers

The directive 'discuss' demands comprehensive coverage with critical analysis across all sub-parts. Allocate approximately 30% time/words to part (a) as it carries 15 marks; 20% each to (b)(i) and (b)(ii) at 10 marks each; 20% to (c)(i); and 10% to (c)(ii). Structure with clear sub-headings for each part, begin with definitions where asked, and ensure clinical-pathological correlations are explicitly stated rather than merely listed.

• (a) Organophosphates: definition as acetylcholinesterase inhibitors; clinical triad of muscarinic, nicotinic and CNS effects; specific antidotes atropine and pralidoxime; postmortem findings including garlic odour, frothy fluid, and constricted pupils
• (b)(i) Benign vs malignant: encapsulation vs invasion, differentiation, mitotic activity, and metastasis; cervical cancer pathogenesis: HPV 16/18 → E6/E7 oncoproteins → p53/Rb inactivation → CIN progression → invasive carcinoma
• (b)(ii) Type I DM pathogenesis: autoimmune destruction of beta cells (HLA-DR3/DR4 association), role of GAD65 and IA-2 antibodies; diabetic nephropathy lesions: diffuse glomerulosclerosis and nodular (Kimmelstiel-Wilson) glomerulosclerosis
• (c)(i) Second-line TB drugs: fluoroquinolones (levofloxacin, moxifloxacin), injectable agents (amikacin, capreomycin), oral bacteriostatics (ethionamide, cycloserine, PAS), and their use in MDR-TB regimens under DOTS-Plus
• (c)(ii) Aldosterone antagonists: spironolactone and eplerenone as competitive antagonists at mineralocorticoid receptors; vasodilatory mechanism via reduced vascular smooth muscle tone and endothelial dysfunction improvement in heart failure

Begin with (a)(i) Aspergillus species enumeration (10 marks), spending ~20% time on species list and infections, then ~15% on lab diagnosis. For (a)(ii) dysentery (10 marks), allocate ~10% to definition, ~15% to comparison table, and ~15% to amoebic lab diagnosis. Move to (b)(i) drowning types (10 marks) with ~20% time, then (b)(ii) hyoid bone (10 marks) with ~15% for diagram and ~15% for fracture discussion. Conclude with (c) pharmacology (10 marks total): ~10% for metformin MOA and ~10% for thiazides. Use tabular format for comparisons and ensure the hyoid diagram is anatomically precise with all muscular attachments labeled.

• (a)(i) Enumerate A. fumigatus (most common, invasive aspergillosis), A. flavus (aflatoxin, keratitis), A. niger (otomycosis, black fungal balls), A. terreus (resistant to amphotericin B), A. clavatus; mention lab diagnosis via KOH mount showing septate hyphae with acute angle branching, culture on Sabouraud dextrose agar, galactomannan antigen, β-D-glucan, and CT halo sign
• (a)(ii) Define dysentery as inflammation of colon with blood/mucus in stools; contrast bacterial (Shigella, abrupt onset, small volume stools, neutrophilic exudate, fever) vs amoebic (Entamoeba histolytica, gradual onset, large volume, 'flask-shaped' ulcers, trophozoites with ingested RBCs); lab diagnosis by stool microscopy (trophozoites/cysts), ELISA for E. histolytica antigen, serology, colonoscopy with biopsy
• (b)(i) Define drowning as death due to immersion/submersion in liquid; classify as wet (80%, aspiration of fluid) vs dry (20%, laryngospasm, no aspiration), fresh vs salt water, secondary (delayed ARDS), and near-drowning; mention autopsy findings (froth, diatoms, emphysema aquosum)
• (b)(ii) Draw hyoid bone showing body, greater horns (cornua), lesser horns, and muscular attachments (stylohyoid, mylohyoid, geniohyoid, digastric); discuss fractures in strangulation (thyrohyoid ligament avulsion), hanging (greater horn fracture), and manual throttling; mention medicolegal significance in suspected homicide
• (c)(i) Explain metformin mechanism: activates AMP-activated protein kinase (AMPK), inhibits hepatic gluconeogenesis, increases peripheral insulin sensitivity, reduces intestinal glucose absorption, and decreases hepatic glycogenolysis; mention no hypoglycemia risk and lactic acidosis contraindication
• (c)(ii) Thiazides indications: hypertension, edema (mild CHF, nephrotic syndrome), nephrogenic diabetes insipidus, hypercalciuria; adverse effects: hypokalemia, hyponatremia, hyperglycemia, hyperuricemia, hyperlipidemia, photosensitivity, and sulfa allergy